{"altmetric_id":2177924,"counts":{"readers":{"mendeley":81,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["255378207924605"],"posts_count":1},"news":{"unique_users_count":2,"unique_users":["il_post","el_mundo"],"posts_count":2},"total":{"posts_count":7},"twitter":{"unique_users_count":4,"unique_users":["Relicena","soanor","AEGRIS2","Silviareboredo"],"posts_count":4}},"selected_quotes":["Avastin vs Lucentis: 1 trabajo franc\u00e9s publicado en Ophtalmology, confirma similitud en eficacia #SegPac #Ptsafety"],"citation":{"abstract":"To evaluate the relative efficacy and safety profile of bevacizumab versus ranibizumab intravitreal injections for the treatment of neovascular age-related macular degeneration (AMD).","abstract_source":"pubmed","altmetric_jid":"4f6fa5113cf058f610003250","authors":["Kodjikian L","Souied EH","Mimoun G","Mauget-Fa\u00ffsse M","Behar-Cohen F","Decullier E","Huot L","Aulagner G"],"doi":"10.1016\/j.ophtha.2013.06.020","first_seen_on":"2014-03-12T01:06:44+00:00","issns":["0161-6420"],"issue":"","journal":"Ophthalmology","last_mentioned_on":1428348160,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23916488","http:\/\/dx.doi.org\/10.1016\/j.ophtha.2013.06.020"],"pmid":"23916488","pubdate":"2013-08-08T00:00:00+00:00","publisher":"American Academy of Ophthalmology","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Ophthalmology And Optometry","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["ophthalmology"],"title":"Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/ranibizumab-versus-bevacizumab-neovascular-agerelated-macular-degeneration-results-gefal-noninferior"},"altmetric_score":{"score":22.95,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":22.95},"context_for_score":{"all":{"total_number_of_other_articles":8002981,"mean":6.7515998143141,"rank":352874,"this_scored_higher_than_pct":95,"this_scored_higher_than":7649832,"rank_type":"exact","sample_size":8002981,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":174454,"mean":7.6446048505904,"rank":10101,"this_scored_higher_than_pct":94,"this_scored_higher_than":164344,"rank_type":"exact","sample_size":174454,"percentile":94},"this_journal":{"total_number_of_other_articles":2470,"mean":10.689225597408,"rank":107,"this_scored_higher_than_pct":95,"this_scored_higher_than":2362,"rank_type":"exact","sample_size":2470,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":33,"mean":3.9150625,"rank":2,"this_scored_higher_than_pct":93,"this_scored_higher_than":31,"rank_type":"exact","sample_size":33,"percentile":93}}},"demographics":{"poster_types":{"member_of_the_public":4},"users":{"twitter":{"cohorts":{"Members of the public":4}},"mendeley":{"by_status":{"Professor > Associate Professor":4,"Librarian":1,"Student  > Doctoral Student":9,"Researcher":12,"Student  > Ph. D. Student":8,"Student  > Postgraduate":5,"Student  > Master":19,"Other":9,"Student  > Bachelor":11,"Lecturer":1,"Professor":2},"by_discipline":{"Medicine and Dentistry":56,"Social Sciences":1,"Physics and Astronomy":1,"Mathematics":1,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Engineering":1,"Chemistry":1,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":10,"Computer Science":1,"Nursing and Health Professions":2,"Biochemistry, Genetics and Molecular Biology":2}}},"geo":{"twitter":{"ES":3,"GD":1},"mendeley":{"US":1,"BR":1,"IL":1,"PE":1,"IS":1,"ES":1}}},"posts":{"news":[{"title":"Il caso di Avastin e Lucentis","url":"http:\/\/www.ilpost.it\/2014\/03\/09\/inchiesta-farmaci-roche-novartis\/","license":"public","citation_ids":[722757,2177924,722529],"posted_on":"2014-03-09T12:30:48+00:00","summary":"Cio\u00e8 i due farmaci per cui l'Antitrust italiana ha condannato due multinazionali farmaceutiche, Roche e Novartis, a una multa di 180 milioni di euro The post Il caso di Avastin e Lucentis appeared first on Il Post .","author":{"name":"Il Post","url":"http:\/\/www.ilpost.it\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/289\/normal\/Screen_Shot_2016-01-27_at_15.55.03.png?1453910120"}},{"title":"\u00a1Permitan recetar f\u00e1rmacos baratos para la ceguera!","url":"http:\/\/www.elmundo.es\/salud\/2015\/04\/03\/551e7d51e2704e83308b4570.html","license":"public","citation_ids":[1635419,2177924,173656,21575610,3861047],"posted_on":"2015-04-03T11:49:56+00:00","summary":"Existen dos medicamentos eficaces para el tratamiento de la degeneraci\u00f3n macular asociada a la edad. Pero s\u00f3lo el m\u00e1s caro est\u00e1 autorizado. La revista BMJ acusa a la industria farmac\u00e9utica de ocultaci\u00f3n deliberada de la evidencia cient\u00edfica por parte de la","author":{"name":"El Mundo","url":"http:\/\/www.elmundo.es\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/173\/normal\/image.png?1369925539"}}],"twitter":[{"url":"https:\/\/twitter.com\/Relicena\/status\/585141202435055617","license":"datasift","rt":["AEGRIS2"],"citation_ids":[2177924],"posted_on":"2015-04-06T18:05:08+00:00","author":{"name":"Elena","image":"https:\/\/pbs.twimg.com\/profile_images\/852619697807925251\/WMd8Kp_C_normal.jpg","description":"La ciencia aprende de los errores","id_on_source":"Relicena","tweeter_id":"1255578158","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":44},"tweet_id":"585141202435055617"},{"url":"https:\/\/twitter.com\/soanor\/status\/585160714119225346","license":"datasift","rt":["AEGRIS2"],"citation_ids":[2177924],"posted_on":"2015-04-06T19:22:40+00:00","author":{"name":"Sonia Anaya","image":"https:\/\/pbs.twimg.com\/profile_images\/602139855439712256\/EsuwqWwx_normal.jpg","description":"Farmaceutica de Atenci\u00f3n Primaria. Por una sanidad p\u00fablica y universal","id_on_source":"soanor","tweeter_id":"400186628","geo":{"lt":12.11667,"ln":-61.66667,"country":"GD"},"followers":139},"tweet_id":"585160714119225346"},{"url":"https:\/\/twitter.com\/AEGRIS2\/status\/585126944418701312","license":"datasift","citation_ids":[2177924],"posted_on":"2015-04-06T17:08:29+00:00","author":{"name":"AEGRIS","url":"http:\/\/www.seguridadasistencial.com","image":"https:\/\/pbs.twimg.com\/profile_images\/877744057170132992\/2e4vhgYX_normal.jpg","description":"L\u00cdDER EN SEGURIDAD DE LOS PACIENTES. Desde 1998 trabajando e investigando en este \u00e1mbito. Queremos compartir para aumentar el inter\u00e9s general por la materia","id_on_source":"AEGRIS2","tweeter_id":"991704662","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":2148},"tweet_id":"585126944418701312"},{"url":"https:\/\/twitter.com\/Silviareboredo\/status\/585133038130044930","license":"datasift","rt":["AEGRIS2"],"citation_ids":[2177924],"posted_on":"2015-04-06T17:32:42+00:00","author":{"name":"Silvia Reboredo","image":"https:\/\/pbs.twimg.com\/profile_images\/2627843455\/7JEy8oAM_normal","description":"Farmac\u00e9utica Atenci\u00f3n Primaria Galicia. Actualmente en la Subdirecci\u00f3n Xeral de Farmacia. Evaluaci\u00f3n de medicamentos.Polimedicados. Apap C. Manuel Peleteiro","id_on_source":"Silviareboredo","tweeter_id":"578833310","geo":{"lt":42.88052,"ln":-8.54569,"country":"ES"},"followers":629},"tweet_id":"585133038130044930"}],"facebook":[{"title":"Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=680014985460923&id=255378207924605","license":"public","citation_ids":[2177924],"posted_on":"2015-04-06T17:08:33+00:00","summary":"Avastin vs Lucentis: 1 trabajo franc\u00e9s publicado en Ophtalmology, confirma similitud en eficacia #SegPac #Ptsafety \nhttp:\/\/t.co\/31luMRbyJC","author":{"name":"Aegris","url":"https:\/\/www.facebook.com\/255378207924605","facebook_wall_name":"Aegris","image":"https:\/\/graph.facebook.com\/255378207924605\/picture","id_on_source":"255378207924605"}}]}}